TTY Biopharm Company Limited (TPEX:4105)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
83.70
-0.40 (-0.48%)
At close: Feb 11, 2026

TTY Biopharm Company Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
20,81218,10219,99120,73717,10717,057
Market Cap Growth
11.16%-9.45%-3.60%21.22%0.29%-16.75%
Enterprise Value
20,82518,29220,06120,68616,70717,498
Last Close Price
83.7068.9072.8372.3257.1954.16
PE Ratio
11.6412.4917.7218.9520.5618.46
Forward PE
14.1112.8614.8117.4516.5413.10
PS Ratio
3.203.073.634.103.774.04
PB Ratio
2.722.413.073.332.972.81
P/TBV Ratio
3.232.843.463.843.393.21
P/FCF Ratio
12.6314.7919.8518.1214.3047.61
P/OCF Ratio
11.6713.4218.4216.7813.6232.41
EV/Sales Ratio
3.203.103.644.093.684.14
EV/EBITDA Ratio
9.0711.5212.8114.6912.8215.75
EV/EBIT Ratio
9.9413.1214.6216.8514.6518.28
EV/FCF Ratio
12.6314.9419.9218.0813.9748.85
Debt / Equity Ratio
0.260.230.290.290.370.35
Debt / EBITDA Ratio
1.061.081.191.281.651.93
Debt / FCF Ratio
1.221.401.851.581.795.98
Asset Turnover
0.590.570.560.540.490.45
Inventory Turnover
1.992.102.082.051.711.64
Quick Ratio
1.451.561.621.351.231.42
Current Ratio
2.012.022.081.731.561.88
Return on Equity (ROE)
25.60%21.68%17.56%18.38%13.89%15.98%
Return on Assets (ROA)
9.56%8.40%8.81%8.12%7.64%6.33%
Return on Invested Capital (ROIC)
20.19%19.22%19.84%18.02%15.73%14.37%
Return on Capital Employed (ROCE)
20.20%17.40%18.80%18.40%18.30%14.10%
Earnings Yield
8.60%8.01%5.64%5.28%4.86%5.42%
FCF Yield
7.92%6.76%5.04%5.52%6.99%2.10%
Dividend Yield
5.02%6.09%4.81%4.70%5.24%7.39%
Payout Ratio
59.11%60.04%74.91%68.16%119.56%107.62%
Buyback Yield / Dilution
-0.01%-0.04%-0.03%0.02%0.00%-0.03%
Total Shareholder Return
5.01%6.06%4.78%4.72%5.25%7.36%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.